Psoriatic Arthritis Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Sun Pharma Global, UCB Biopharma, Pfizer, Bristol-Myers Squibb, AbGenomics, Boehringer Ingelheim

June 10 16:13 2021
Psoriatic Arthritis Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Sun Pharma Global, UCB Biopharma, Pfizer, Bristol-Myers Squibb, AbGenomics, Boehringer Ingelheim

Psoriatic Arthritis Pipeline

Psoriatic Arthritis is a chronic inflammatory disease of the joints that can be associated with the psoriasis. It can affect both peripheral joints and axial skeleton causing pain, stiffness, swelling and joint destruction. This joint pathology develops gradually and cause more nuisance than disabling. Psoriatic arthritis is considered as seronegative spondyloarthropathies. The fact that it is Seronegative is that the blood tests negative for some factors that is present in rheumatoid arthritis. Spondyloarthropathy describes a group of conditions that all share common characteristics. First, there is a presence of arthritis that affects the spine. Second, inflammation occurs in ligaments, tendons and sometimes in other organs such as the eye.

DelveInsight’s, “Psoriatic arthritis Pipeline Insight, 2021” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Psoriatic arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.


Request for Free Sample Report:


Some of Psoriatic Arthritis Companies are:

  • Sun Pharma Global
  • UCB Biopharma
  • Pfizer
  • Bristol-Myers Squibb
  • AbGenomics
  • Boehringer Ingelheim
  • Affibody
  • AltruBio
  • Synact Pharma
  • NeuClone
  • 3SBio
  • Qyuns Therapeutics
  • Kangpu Biopharmaceuticals
  • Alpine Immune Sciences
  • Avotres
  • Xbrane Biopharma
  • XBiotech
  • Evelo
  • Luye Pharma Group
  • Levolta Pharmaceuticals
  • DNX Biopharmaceuticals
  • Mycenax Biotech
  • And Many Others


Request for Free Sample Report:


DelveInsight’s Psoriatic Arthritis report covers around 35+ products under different phases of clinical development like

  • Late stage products (Phase III)
  • Mid-stage products (Phase II)
  • Early-stage product (Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates


Some of Psoriatic Arthritis Therapies are:

  • Tildrakizumab
  • Bimekizumab
  • PF-06700841
  • BMS-986165
  • AbGn-168H
  • BI 730357
  • Izokibep
  • Neihulizumab
  • AP1189
  • NeuLara
  • Apremilast
  • QX 002N
  • KPG-612
  • ALPN 101
  • AVT001
  • Xcimzane
  • RHE 70202
  • EDP1815
  • DNX 514
  • DNX 114
  • And Many Others


Request for Free Sample Report:


Current Psoriatic Arthritis Treatment Scenario and Psoriatic Arthritis Emerging Therapies:

  • How many companies are developing Psoriatic arthritis drugs?
  • How many Psoriatic arthritis drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Psoriatic arthritis?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Psoriatic arthritis therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Psoriatic arthritis and their status?
  • What are the key designations that have been granted to the emerging drugs?


Request for Free Sample Report:


Table of Contents:

Executive Summary
Psoriatic arthritis: Overview
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
Psoriatic arthritis – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
• Psoriatic arthritis companies’ collaborations, Licensing, Acquisition -Deal Value Trends
Psoriatic arthritis Collaboration Deals
Late Stage Products (Preregistration)
• Comparative Analysis
Tildrakizumab: Sun Pharma Global
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
BMS-986165: Bristol-Myers Squibb
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
• Comparative Analysis
Apremilast: 3SBio
Drug profiles in the detailed report…..
Preclinical and Discovery stage Products
• Comparative Analysis
ALPN 101: Alpine Immune Sciences
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Psoriatic arthritis Key Companies
Psoriatic arthritis Key Products
Psoriatic arthritis- Unmet Needs
Psoriatic arthritis- Market Drivers and Barriers
Psoriatic arthritis- Future Perspectives and Conclusion
Psoriatic arthritis Analyst Views
Psoriatic arthritis Key Companies


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States

view more articles

About Article Author